Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

aafp.org

1 of 0

Resource Description:

The FDA announced last month that it would require manufacturers of tumor necrosis factor, or TNF, blockers to strengthen their products package label warnings to highlight potential risks for opportunistic fungal infections that can result in death.

« Back to the TNF Blockers WisdomCard

Related Health Centers:

Advertisement